Illustration: Thromboelastography - A useful tool to monitor COVID-19-associated coagulopathy

Document Type

Article

Publication Title

Asian Journal of Transfusion Science

Abstract

COVID 19 is caused by Severe Acute Respiratory Syndrome Corona Virus-2 which results in wide range of manifestations. Systemic hypercoagulation is a typical feature of COVID-19. We present a case of COVID-19 in whom TEG was performed on admission and hypercoagulability was diagnosed and hence patient was started on Enoxaparin sodium 6000 IU twice daily. TEG was repeated after 5 days which showed normal coagulation status and the patient was discharged without any thrombotic complications.

First Page

148

Last Page

149

DOI

10.4103/ajts.ajts_73_21

Publication Date

1-1-2022

This document is currently not available here.

Share

COinS